These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1099282)

  • 21. Growth and toxin production of Clostridium botulinum types E, nonproteolytic B, and F in nonirradiated and irradiated fisheries products in the temperature range of 38 degrees to 50 degrees F. TID-25231.
    Eklund MW; Poysky FT
    TID Rep; 1969 Jan; ():1-33. PubMed ID: 4905817
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: Clostridium botulinum type A, B, E and F 12S toxins.
    Kozaki S; Sugii S; Oishi I; Sakaguchi S; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Feb; 28(1):70-2. PubMed ID: 1099283
    [No Abstract]   [Full Text] [Related]  

  • 23. The quantitative determination of the toxic factors produced by Clostridium botulinum (Van Ermengem, 1896) types C and D.
    Jansen BC
    Onderstepoort J Vet Res; 1971 Sep; 38(3):177-9. PubMed ID: 4950837
    [No Abstract]   [Full Text] [Related]  

  • 24. Phage-conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Jpn J Med Sci Biol; 1977 Feb; 30(1):40-3. PubMed ID: 406437
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of structural genes for Clostridium botulinum type C neurotoxin-converting phage particles.
    Hwang HJ; Lee JC; Yamamoto Y; Sarker MR; Tsuchiya T; Oguma K
    FEMS Microbiol Lett; 2007 May; 270(1):82-9. PubMed ID: 17302935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The origin, structure, and pharmacological activity of botulinum toxin.
    Simpson LL
    Pharmacol Rev; 1981 Sep; 33(3):155-88. PubMed ID: 6119708
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of enrichment semi-nested PCR for Clostridium botulinum types A, B, E, and F and its application to Korean environmental samples.
    Shin NR; Yoon SY; Shin JH; Kim YJ; Rhie GE; Kim BS; Seong WK; Oh HB
    Mol Cells; 2007 Dec; 24(3):329-37. PubMed ID: 18182847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and taxonomic significance of bacteriophages for non-proteolytic Clostridium botulinum.
    Sugiyama H; King GJ
    J Gen Microbiol; 1972 May; 70(3):517-25. PubMed ID: 4556256
    [No Abstract]   [Full Text] [Related]  

  • 29. [Toxigenicity of Clostridium botulinum. 2. Correlation between toxigenicity and sporulating potency].
    Yamagishi T; Kawai Y
    Igaku To Seibutsugaku; 1966 Oct; 73(4):219-23. PubMed ID: 5342036
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation and characterization of converting and non-converting phages, harbored in the strains of Clostridium botulinum types C and D isolated in Japan.
    Sunagawa H; Inoue K
    J Vet Med Sci; 1991 Oct; 53(5):951-4. PubMed ID: 1836387
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bacteriophages and bacteriocins of Clostridium botulinum].
    Donets IuI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):12-7. PubMed ID: 354284
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacteriophage and the toxigenicity of Clostridium botulinum type D.
    Eklund MW; Poysky FT; Reed SM
    Nat New Biol; 1972 Jan; 235(53):16-7. PubMed ID: 4553461
    [No Abstract]   [Full Text] [Related]  

  • 33. [ANTIGENIC SPECIFICITY OF CL. BOTULINUM TYPES C, D, E].
    SHEVELEV VM; VORONOVA ZA; REZEPOV FF
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Mar; 41():65-9. PubMed ID: 14187965
    [No Abstract]   [Full Text] [Related]  

  • 34. [A bacteriophage in a culture of Cl. botulinum type C].
    Vinet G; Berthiaume L; Fredette V
    Rev Can Biol; 1968 Mar; 27(1):73-4. PubMed ID: 4883802
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacteriophages of Clostridium botulinum.
    Inoue K; Iida H
    J Virol; 1968 May; 2(5):537-40. PubMed ID: 4880051
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Infect Immun; 1976 Mar; 13(3):855-60. PubMed ID: 773828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Bacteriophages and toxigenicity in Clostridium botulinum types C and D.
    Oguma K; Iida H; Inoue K
    Jpn J Med Sci Biol; 1975 Feb; 28(1):63-6. PubMed ID: 1099282
    [No Abstract]   [Full Text] [Related]  

  • 38. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Iida H; Oguma K; Inoue K
    Jpn J Med Sci Biol; 1974 Apr; 27(2):101-3. PubMed ID: 4601039
    [No Abstract]   [Full Text] [Related]  

  • 39. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K; Iida H
    Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.